Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells

Allogeneic human cardiac-derived stem/progenitor cells (hCPC) are currently under clinical investigation for cardiac repair. While cellular immune response against allogeneic hCPC could be part of their beneficial-paracrine effects, their humoral immune response remains largely unexplored. Donor-spe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Hocine, Hocine R., Costa, Hicham E. L., Dam, Noemie, Giustiniani, Jerome, Palacios, Itziar, Loiseau, Pascale, Benssusan, Armand, Borlado, Luis R., Charron, Dominique, Suberbielle, Caroline, Jabrane-Ferrat, Nabila, Al-Daccak, Reem
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5259698/
https://ncbi.nlm.nih.gov/pubmed/28117403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep41125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados